Amyloidosis

NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis

A Phase 3 Study of NTLA-2001 in ATTRv-PN

A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis

Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis

Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load

Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis

Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

BE.Amycon Biobank & Data Registry UZ Leuven

24 Month Open Label Study of the Tolerability and Efficacy of Inotersen in TTR Amyloid Cardiomyopathy Patients

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Study of Olfactory Disorders in Patients With Cardiac Amyloidosis

A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)

Expanded Access to Venetoclax

HIBA-Institutional Registry of Amyloidosis

Institutional Registry of Rare Diseases

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)